Shelton Capital Management’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.45M | Sell |
62,419
-2,222
| -3% | -$194K | 0.13% | 149 |
|
|
2025
Q1 | $4.41M | Sell |
64,641
-1,743
| -3% | -$119K | 0.11% | 163 |
|
|
2024
Q4 | $5.16M | Buy |
66,384
+15
| +0% | +$1.17K | 0.13% | 150 |
|
|
2024
Q3 | $4.45M | Buy |
66,369
+16,025
| +32% | +$1.07M | 0.11% | 162 |
|
|
2024
Q2 | $5.71M | Buy |
50,344
+2,048
| +4% | +$232K | 0.16% | 135 |
|
|
2024
Q1 | $6.7M | Buy |
48,296
+727
| +2% | +$101K | 0.19% | 124 |
|
|
2023
Q4 | $5.9M | Buy |
47,569
+4,052
| +9% | +$503K | 0.19% | 131 |
|
|
2023
Q3 | $4.06M | Buy |
43,517
+9,340
| +27% | +$871K | 0.15% | 164 |
|
|
2023
Q2 | $4.39M | Buy |
34,177
+1,329
| +4% | +$171K | 0.16% | 137 |
|
|
2023
Q1 | $3.82M | Buy |
32,848
+2,380
| +8% | +$277K | 0.16% | 140 |
|
|
2022
Q4 | $3.45M | Sell |
30,468
-6,552
| -18% | -$742K | 0.36% | 86 |
|
|
2022
Q3 | $2.98M | Buy |
37,020
+1,220
| +3% | +$98.3K | 0.14% | 158 |
|
|
2022
Q2 | $2.67M | Hold |
35,800
| – | – | 0.12% | 179 |
|
|
2022
Q1 | $4.58M | Hold |
35,800
| – | – | 0.17% | 133 |
|
|
2021
Q4 | $4.81M | Buy |
35,800
+1,316
| +4% | +$177K | 0.17% | 132 |
|
|
2021
Q3 | $4.71M | Buy |
34,484
+808
| +2% | +$110K | 0.18% | 120 |
|
|
2021
Q2 | $3.6M | Hold |
33,676
| – | – | 0.14% | 165 |
|
|
2021
Q1 | $3.03M | Buy |
33,676
+3,080
| +10% | +$277K | 0.11% | 186 |
|
|
2020
Q4 | $2.83M | Buy |
30,596
+1,180
| +4% | +$109K | 0.13% | 160 |
|
|
2020
Q3 | $3.03M | Hold |
29,416
| – | – | 0.13% | 180 |
|
|
2020
Q2 | $2.98M | Buy |
+29,416
| New | +$2.98M | 0.16% | 118 |
|